圣诺生物(688117.SH)：前三季度净利润1.27亿元，同比增长123.03%

Core Insights - The company, Saint Noble Biotechnology (688117.SH), reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong financial performance [1] Financial Performance - Total operating revenue reached 520 million yuan, representing a year-on-year growth of 53.96% [1] - Net profit attributable to shareholders was 127 million yuan, showing a year-on-year increase of 123.03% [1] - Basic earnings per share were reported at 0.81 yuan [1] Dividend Announcement - The company plans to distribute a cash dividend of 0.3176 yuan (including tax) for every 10 shares to all shareholders [1]